DANIEL BROWN: Open Payments
NPI 1194826602 · FT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,322 in 43 payments from 9 companies in 2025. Trend: 2023 $2,434 · 2024 $1,876 · 2025 $1,322
Food & beverage: $1,322
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 26 | $477 |
| Gilead Sciences, Inc. | 5 | $324 |
| EMD Serono, Inc. | 4 | $190 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Hologic Sales and Service, LLC | 3 | $74 |
| Theratechnologies Inc. | 1 | $36 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| ABBVIE INC. | 1 | $27 |
| Napo Pharmaceuticals Inc | 1 | $21 |
Products named: Biktarvy, DOVATO, REZDIFFRA, Yeztugo, CABENUVA, APRETUDE, RUKOBIA, APTIMA.
Industry payments across FL — which companies pay providers there.
